Hong Kong SAR

Barclays has made Sushir Lohia head of global finance and risk solutions (GFRS) for Asia Pacific, according to an internal memo seen by GlobalCapital Asia.

HSBC has decided to remain headquartered in the UK following an extensive review by its board of directors, ending months of speculation that it could return to Hong Kong.

Chinese pharmaceutical company Hutchison China MediTech (Chi-Med) has picked a quartet of co-managers for a $100m listing on the Nasdaq.

The Hong Kong Stock Exchange has published a guide to help potential issuers produce clear listing documents, as it fears investors are drowning in a sea of jargon.

Clifford Modern Living Holdings, which provides property management services in China, has filed to list in Hong Kong via sole sponsor Guotai Junan Capital.

China Resources Pharmaceutical Group and Union Medical Healthcare (UMH) are planning to bring IPOs to Hong Kong this year and potentially raise a combined $1.15bn.

In this round-up, Charles Li promises Bond Connect and RMB derivatives, ICBC sees cross-border business booming, Moscow Exchange looks to connect with Chinese investors, offshore RMB (CNH) still a top three currency on the EBS FX trading platform, and China clarifies rules for foreign banks looking to join the onshore FX market. Plus, a recap of the top GlobalRMB stories this week.

Goodbaby China Holdings has pulled its HK$1.3bn ($167.0m) Hong Kong IPO, deciding to cancel on the day it was due to price. Volatile markets and a weaker than expected book meant the leads decided to play it safe.

We in the banking industry always like to think of ourselves as charming, funny individuals. How could we not be, since most of us, bar the incomprehensible quants, earn our money by flogging stuff.

Chinese biopharmaceutical company BeiGene has raised $158m from a Nasdaq IPO after increasing the size of the offer and pricing it at the top of guidance.

Investors have stayed quiet as GCL New Energy attempted a rights issue to raise as much as HK$2.5bn ($320.6m), with only one proper application made for the offer, leaving a third unaccounted for.

Hong Kong’s stock market regulator has publicly censured Goldman Sachs for breaches of the Code on Takeovers and Mergers, it said in a statement on Tuesday.